| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Erytech Pharma SA is a France based clinical-stage biopharmaceutical company. It is engaged conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. The approach by the firm consists of acting on the tumor's environment and starving it so that the cancerous cells no longer have access to the growth factors that are necessary to live and proliferate. Most of the activities of the group are located in France.
| |